Targeted degradation of the oncogenic phosphatase SHP2
Vemulapalli, V.; Donovan, K. A.; Seegar, T.; Rogers, J. M.; Bae, M.; Lumpkin, R.; Cao, R.; Henke, M.; Fischer, E. S.; Cuny, G.; Blacklow, S. C.
Show abstract
SHP2 is a protein tyrosine phosphatase that plays a critical role in the full activation of the Ras/MAPK pathway upon stimulation of receptor tyrosine kinases (RTKs), which are frequently amplified or mutationally activated in human cancer. In addition, activating mutations in SHP2 result in developmental disorders and hematologic malignancies. Several allosteric inhibitors have been developed for SHP2 and are currently in clinical trials. Here, we report the development and evaluation of a SHP2 PROTAC created by conjugating RMC-4550 with pomalidomide using a PEG linker. This molecule is highly selective for SHP2, induces degradation of SHP2 in leukemic cells at sub-micromolar concentration, inhibits MAPK signaling, and suppresses cancer cell growth. SHP2 PROTACs serve as an alternative strategy for targeting ERK-dependent cancers and are useful tools alongside allosteric inhibitors for dissecting the mechanisms by which SHP2 exerts its oncogenic activity.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy in vivo 98%
- Rational Design and Optimization of a Potent IDO1 Proteolysis Targeting Chimera (PROTAC) 98%
- Development of a chemical probe to enable characterization of the casein kinase 1γ subfamily 98%
Similar papers in this journal
- Shifting the selectivity of pyridopyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily 97%
- Substitutions at the C-8 position of quinazolin-4-ones improve the potency of nicotinamide site binding tankyrase inhibitors 97%
- Discovery of novel 1,4-dicarbonylthiosemicarbazides as DNA gyrase inhibitors for the treatment of MRSA infection 97%
Similar papers in this journal
Similar papers in this journal
- Design and analysis of the 4-anilino-quin(az)oline kinase inhibition profiles of GAK/SLK/STK10 using quantitative structure activity relationships 97%
- Targeting the water network in cyclin G associated kinase (GAK) with 4-anilino-quin(az)oline inhibitors 96%
- Discovery of ICOS-targeted small molecules using affinity selection mass spectrometry screening 91%
Similar papers in this journal
- Discovery of a new class of reversible TEA-domain transcription factor inhibitors with a novel binding mode 95%
- Stereo-specific Lasofoxifene Derivatives Reveal the Interplay between Estrogen Receptor Alpha Stability and Antagonistic Activity in ESR1 Mutant Breast Cancer Cells 95%
- Expanding Automated Multiconformer Ligand Modeling to Macrocycles and Fragments 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.